Clermont-Ferrand, 3 July 2018 – (FR0004177046 METEX), METabolic EXplorer (METEX), an industrial biochemical company specialising in the development and industrial application of green and sustainable fermentation processes, announces the financing of its planned propanediol (PDO) and butyric acid (BA) production unit at the Carling Saint-Avold industrial platform. The METEX project will receive financing from local public and private stakeholders. METEX concurrently announces the signature of an agreement with Bpifrance for the creation of METEX NØØVISTA, a joint venture to be majority-held by METEX that will build and operate this unit. This agreement follows on the letter of intent signed on 29 January 2018.
METEX reiterates that the planned production unit will have a capacity of 24 kt/year, to be achieved in two stages: a first, 6-kt stage (5 kt of PDO and 1 kt of BA) and a second, 18-kt stage (15 kt of PDO and 3 kt of BA).
It is reminded that the total financing to be provided by the METEX NØØVISTA joint venture partners for the project, excluding buildings and utilities, will stay at the same maximum amount of €37 million as estimated in January 2018.
Bpifrance would make an equity investment alongside METEX. METEX is committed to providing €17.2 million in cash along with an exclusive licence and sub-licencing rights, to be remunerated by a royalty fee on revenues in the vicinity of a mid-single-digit percentage and an upfront fee in equity. METEX will have a 55% stake in the joint venture. The licencing agreement also provides for an additional valuation of the technology when the project moves into the second stage. Last, in the framework of the Voluntary Economic and Social Development Agreement signed by the Total group, the State, and the Region, local public and private stakeholders will provide financing for this project.
As a reminder, with the technology provided by METEX, it is possible to obtain two distinct products (PDO and BA) using a single process. These two products have several markets, the main ones being, for PDO, cosmetics and bio-based polymers, and for BA, animal nutrition and flavours and fragrances.
The targeted markets for PDO:
The targeted markets for butyric acid:
This production plant will allow marketing of PDO directly and BA for animal nutrition through distribution agreements. The plan is to launch marketing of these products no later than 24 months after construction of the plant begins. METEX is ultimately targeting a 50% share of the PDO market for cosmetics and a 20% share of the natural BA market for animal nutrition.
Confirmation of this financing for the construction of the production unit will be finally granted by the involved parties and public entities upon completion of the usual conditions precedent, in particular on obtaining the building permits and the environmental authorisation for its operation (Autorisation Environnementale d’Exploiter), which are currently under review. Considering that the public enquiry was opened on 28 June 2018, these permits and authorisations should be obtained by the end of 2018.
[1] Source: Expert interviews, Advancy analysis
[2] Source: Expert interviews, Advancy analysis
– END –
About METabolic EXplorer – www.metabolic-explorer.com
A pioneer in industrial biochemistry with some 20 years of experience, METabolic Explorer (METEX) develops alternative solutions to the petrochemical processes used in manufacturing.
Using renewable raw materials, it develops innovative industrial fermentation processes to produce competitive chemical compounds used in basic products of everyday life such as animal nutrition and health additives, plastics, textiles, cosmetics, and resins, among many others.
The company’s ambition with its biotechnological innovations is to produce consumer goods in a different way, without oil, in order to meet consumers’ new societal expectations and the objectives of the energy transition and sustainable development.
To create these innovative processes, METabolic EXplorer relies on a 70-person staff possessing the complementary competencies essential at every step of their development, from the optimization of biochemical catalysts in the laboratory to the industrial validation and production of samples in an industrial demonstration unit in continuous operation.
Based at the Clermont Limagne technology park, near Clermont-Ferrand, METabolic Explorer is listed on Euronext in Paris (Compartment C, METEX) and is included in the CAC Small Index.
Get free financial information on METabolic EXplorer by registering with:
www.metabolic-explorer.com
Investor relations – ACTIFIN –
Benjamin LEHARI
Tél : + 33 (0) 1 56 88 11 11
mail : blehari@actifin.fr
Media relations – ACTIFIN –
Jenna DRIFF
Tél : + 33 (0) 1 56 88 11 11
mail : jdriff@actifin.fr